The Wistar Institute announced that it has signed a funding agreement with the Wellcome Trust, a United Kingdom-based charity, to support the development of a new drug to treat cancers associated with Epstein-Barr virus (EBV). The Seeding Drug Discovery Award of up to $4.7 million will support on-going translational research in the laboratory of Wistar Professor Paul M. Lieberman, Ph.D...
Blood Test Might Predict How Well A Depressed Patient Responds To Antidepressants
12/16/2011
Loyola University Medical Center researchers are reporting what could become the first reliable method to predict whether an antidepressant will work on a depressed patient. The method would involve a blood test for a protein called vascular endothelial growth factor (VEGF)...
Less Blood Clot Damage With Extra Treatment
12/16/2011
Roughly half the people who get a serious blood clot in the leg experience lasting damage. Norwegian researchers are the first to show that a little-used supplementary treatment can help to prevent such complications...
Survival Of Gynecological Cancer Improved In The Anglia Region Of England
12/16/2011
Gynaecological cancer survival rates have improved in Eastern England following the reorganisation of services and multidisciplinary team working finds a new study published in the gynaecological oncology themed issue of BJOG: An International Journal of Obstetrics and Gynaecology...
Vaccine Developed That Successfully Attacks Breast Cancer In Mice
12/16/2011
Researchers at Mayo Clinic in Arizona and the University of Georgia (UGA) have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases - including those that are resistant to common treatments...
Likely Spread Or Recurrence Of Breast Cancer Predicted By New Test
12/16/2011
A Queensland University of Technology (QUT) PhD student has developed a potential breakthrough test for predicting the likelihood of the spread or return of breast cancer...
Vaccine Developed That Successfully Attacks Breast Cancer In Mice
12/16/2011
Researchers at Mayo Clinic in Arizona and the University of Georgia (UGA) have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases - including those that are resistant to common treatments...
HPV DNA Testing Advised For Females Over 30
12/15/2011
HPV DNA testing is better than cytology alone in preventing cervical cancer or detecting it early on for women over thirty, researchers reported in The Lancet Oncology. The authors explained, after reporting on the POBASCAM trial, that they now have compelling evidence in favour of routine HPV testing in national screening programs...
HPV DNA Testing Advised For Females Over 30
12/15/2011
HPV DNA testing is better than cytology alone in preventing cervical cancer or detecting it early on for women over thirty, researchers reported in The Lancet Oncology. The authors explained, after reporting on the POBASCAM trial, that they now have compelling evidence in favour of routine HPV testing in national screening programs...
Gene Mechanism That Stops Colorectal Cancer Modelled In Mice
12/15/2011
A research team in France has bred a lab mouse with a gene mutation that allows colorectal cancer tumors to grow because the protein coded by the gene is no longer able to trigger cell suicide ("apoptosis"). They hope their discovery will pave the way for developing a treatment that targets the gene so it reactivates apoptosis in cancer cells...